glp 1 and gout GLP-1 weight loss drugs could increase risk of osteoporosis gout, new research finds Targeting GLP-1, GIP & GCG

Although short-term use of unapproved peptides appears to be mostly safe, the larger concern lies with downstream side effects that we just dont know about, says Cushman

Additionally, a thorough medical history and physical examination are essential to rule out other potential causes of the symptoms, ensuring that patients receive the appropriate care and management for their condition

Research Finds Injectable Medications for Obesity Produce Smaller Weight Loss in A Real-World Setting

The clinical integration of GLP-1RAs represents a pathway advancement rather than a direct reproductive induction therapy

2003 Oct 10;278(41):39794-800